Microbot Medical Inc (NASDAQ:MBOT) shares, rose in value on Friday, March 28, with the stock price down by -4.58% to the previous day’s close as strong demand from buyers drove the stock to $1.46.
Actively observing the price movement in the last trading, the stock closed the session at $1.53, falling within a range of $1.43 and $1.5. The value of beta (5-year monthly) was 1.606. Referring to stock’s 52-week performance, its high was $3.38, and the low was $0.82. On the whole, MBOT has fluctuated by -1.35% over the past month.
With the market capitalization of Microbot Medical Inc currently standing at about $50.73 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MBOT’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of MBOT currently trading nearly -3.82% and -15.82% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.47, while the 7-day volatility ratio is showing 7.59% which for the 30-day chart, stands at 8.26%. Furthermore, Microbot Medical Inc (MBOT)’s beta value is 1.42, and its average true range (ATR) is 0.14.
A comparison of Microbot Medical Inc (MBOT) with its peers suggests the former has fared considerably weaker in the market. MBOT showed an intraday change of -4.58% in last session, and over the past year, it grew by 29.78%%.
Data on historical trading for Microbot Medical Inc (NASDAQ:MBOT) indicates that the trading volumes over the past 10 days have averaged 1.01 and over the past 3 months, they’ve averaged 4.22 million. According to company’s latest data on outstanding shares, there are 34.74 million shares outstanding.
Nearly 8.78% of Microbot Medical Inc’s shares belong to company insiders and institutional investors own 6.91% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.13 million shares as on 2025-03-14, resulting in a short ratio of 3.49. According to the data, the short interest in Microbot Medical Inc (MBOT) stood at 1481.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 4.76 million. The stock has risen by 30.36% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MBOT stock heading into the next quarter.
